NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE BREAST CANCER RESEARCH FOUNDATION INC, founded in 1993, is a major nonprofit in the Public Safety sector that reported $102.3M in total revenue in fiscal year 2024. Revenue decreased 13% compared to the prior year. Expenses of $94.8M left a modest 7% surplus.
THE MISSION OF THE BREAST CANCER RESEARCH FOUNDATION, INC. IS TO PREVENT AND CURE BREAST CANCER BY ADVANCING THE WORLD'S MOST PROMISING RESEARCH.
BREAST CANCER IS A COMPLEX DISEASE WITH NO SIMPLE SOLUTION. EVERY DIAGNOSIS IS UNIQUE AND PUTS LIVES AT RISK. WE MUST STOP BREAST CANCER IN ITS TRACKS, AND RESEARCH IS THE ANSWER. FOUNDED IN 1993 BY...
BREAST CANCER IS A COMPLEX DISEASE WITH NO SIMPLE SOLUTION. EVERY DIAGNOSIS IS UNIQUE AND PUTS LIVES AT RISK. WE MUST STOP BREAST CANCER IN ITS TRACKS, AND RESEARCH IS THE ANSWER. FOUNDED IN 1993 BY EVELYN H. LAUDER, THE BREAST CANCER RESEARCH FOUNDATION, INC. IS THE LARGEST PRIVATE FUNDER OF BREAST CANCER RESEARCH IN THE WORLD. WE INVEST IN A WIDE RANGE OF RESEARCH - FROM PREVENTION TO METASTASIS - BECAUSE EACH AREA OF INVESTIGATION INFORMS ANOTHER, PROPELLING US TOWARD THE SOLUTIONS WE URGENTLY NEED. WE CONVENE AND CONNECT THE BEST MINDS IN SCIENCE - GIVING THEM THE OPPORTUNITY TO PURSUE THEIR MOST INNOVATIVE IDEAS. OUR COMBINATION OF INVESTMENT AND CROSS-DISCIPLINARY COLLABORATION ACCELERATES THE ENTIRE FIELD AND BUILDS MOMENTUM FOR NEW DISCOVERIES. BCRF - FUNDED INVESTIGATORS HAVE BEEN BEHIND EVERY MAJOR BREAKTHROUGH IN BREAST CANCER RESEARCH, AND THE FIELD IS MOVING FASTER THAN EVER.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $102,321,724 | $117,378,452 | -0.1% |
| Expenses | $94,845,424 | $89,147,787 | +0.1% |
| Net Income | $7,476,300 | $28,230,665 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| KAREN HALE | CO-CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KINGA LAMPERT | CO-CHAIR EMERITUS/DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM LAUDER | CO-CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DEBORAH KRULEWITCH | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BETSY BATTLE | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DONNA ACQUAVELLA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEROME BETTIS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD VAN DEN BROEK | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CYNTHIA CITRONE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NINA GARCIA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LYUBA GOLSTER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| EFFRAIM GRINBERG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SUSAN HERTOG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM KAROL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SHELLY KIVELL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KAY KRILL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CARLYN S MCCAFFREY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ELLEN ODONER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THOMAS QUICK | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ABBE RAVEN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| WENDI ROSE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KENDRA SCOTT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KECIA STEELMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KELLEY TUTHILL | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KERONE VATEL TO 72024 | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DONNA MCKAY | PRESIDENT AND CEO | 40.00 |
Officer
|
$695,061 | $57,500 | $752,561 |
| LISA C RISI | CFO/COO (TO 02/25) | 40.00 |
Officer
|
$409,207 | $59,248 | $468,455 |
| ASHLEY CAREY | CHIEF PARTNERSHIPS OFFICER | 40.00 |
Key Emp
|
$236,826 | $52,433 | $289,259 |
| DORRAYA EL-ASHRY | CHIEF SCIENTIFIC OFFICER | 40.00 |
Key Emp
|
$379,794 | $50,086 | $429,880 |
| STEPHANIE HAMBURGER TO 924 | EXECUTIVE DIRECTOR PLAY FOR P.I.N.K | 40.00 |
Key Emp
|
$183,041 | $9,175 | $192,216 |
| KATHERINE MINSTER | CHIEF DEVELOPMENT OFFICER | 40.00 |
Key Emp
|
$296,547 | $46,778 | $343,325 |
| JODI PATKIN | CHIEF MARKETING/COMM. OFFICER | 40.00 |
Key Emp
|
$300,306 | $30,927 | $331,233 |
| REBECCA WASSERMAN | MNG DIR DEVELOPMENT/REGIONAL EVENTS | 40.00 |
Highest
|
$195,224 | $28,840 | $224,064 |
| KATHLEEN TRIPP | DIRECTOR DIGITAL COMMUNICATIONS | 40.00 |
Highest
|
$256,436 | $36,805 | $293,241 |
| KATHERINE ANDERSON | MNG DIR DEVELOP/SIGNATURE EVENTS | 40.00 |
Highest
|
$194,897 | $41,413 | $236,310 |
| SADIA HAQUE ZAPP | MANAGING DIR COMMUNICATIONS/CONTENT | 40.00 |
Highest
|
$184,561 | $49,158 | $233,719 |
| MARGARET FLOWERS | MANAGING DIRECTOR RESEARCH PROGRAM | 40.00 |
Highest
|
$182,490 | $31,661 | $214,151 |
| MYRA J BIBLOWIT | FORMER PRESIDENT AND CEO (3/31/23) | 0.00 |
|
$190,172 | $0 | $190,172 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $102,321,724 | $94,845,424 | $220,475,969 | $7,476,300 |
| 2024 | $117,378,452 | $89,147,787 | $199,068,927 | $28,230,665 |
| 2023 | $94,756,928 | $77,854,319 | $153,390,978 | $16,902,609 |
| 2022 | $84,528,969 | $69,884,036 | $129,940,554 | $14,644,933 |
| 2021 | $64,523,080 | $61,434,061 | $117,751,822 | $3,089,019 |
| 2020 | $76,216,662 | $57,935,627 | $105,214,603 | $18,281,035 |
| 2019 | $79,556,601 | $82,215,778 | $109,896,033 | $-2,659,177 |
Compare THE BREAST CANCER RESEARCH FOUNDATION INC with other nonprofits in New York and across the country.